Do Statins Cause Tendon Problems? What a Major Study Found
- 2 days ago
- 6 min read
By Dr. Jeffrey Peng, MD · Published March 5, 2026 · 8 min read
Watch the Full Video
If you take a statin medication for cholesterol management, you may have experienced tendon pain and wondered whether the two are connected. For years, patients have reported tendon problems while on statins, but the scientific evidence has been mixed. A large nationwide cohort study now provides some of the strongest evidence to date confirming that statin use is associated with a significantly higher risk of developing tendinopathies.
In this article, I break down the key findings from this study, explain which statins carry the highest risk, discuss whether long-term use increases your chances of tendon injury, and share evidence-based strategies you can use to protect your tendons and improve your metabolic health.
What Are Statins and Why Are They Prescribed?
Statins are a class of medications used to lower cholesterol levels and reduce the risk of cardiovascular disease. They work by inhibiting an enzyme involved in cholesterol production in the liver, which leads to lower levels of low-density lipoprotein (LDL) cholesterol in the blood. Statins are among the most widely prescribed medications in the world and have been shown to reduce the risk of heart attacks, strokes, and the need for surgical interventions such as angioplasty and coronary artery bypass surgery.
Statins are commonly prescribed for individuals with risk factors for heart disease, including high cholesterol, diabetes, and hypertension. While their cardiovascular benefits are well established, concerns about side effects — particularly their effects on the musculoskeletal system — have persisted. Many studies have confirmed that statins can cause muscle-related side effects such as myalgia and, in rare cases, rhabdomyolysis. However, less attention has been paid to their potential effects on tendons.
Do Statins Cause Tendon Problems? What the Research Shows
The relationship between statins and tendon disorders has been debated in the medical literature. Some earlier studies suggested that statins increase the risk of tendinopathies and even tendon ruptures, while others reported no significant association or even a protective effect. The conflicting results made it difficult to draw firm conclusions.
A 2023 nationwide population-based cohort study by Kwak et al. provided much-needed clarity. The researchers analyzed data from over 84,000 statin users and matched them against 168,000 controls. They tracked the development of five types of tendinopathy: trigger finger, De Quervain's tenosynovitis, tennis elbow and golfer's elbow, rotator cuff tendinopathy, and Achilles tendinitis.
The results were clear: statin users had a 43.5% higher risk of developing tendinopathy compared to non-statin users (hazard ratio 1.435, 95% CI 1.411–1.460). While this relative increase sounds dramatic, it is important to consider the absolute numbers. The difference amounted to approximately 10 additional tendinopathy cases per 10,000 person-years among statin users — a meaningful but modest increase when weighed against the potential life-saving benefits of statin therapy for high-risk patients.
Which Statins Carry the Highest Risk for Tendinopathy?
The study specifically examined atorvastatin, rosuvastatin, and simvastatin. The researchers found that atorvastatin and simvastatin had the highest rates of tendinopathy across all tendon types examined. Rosuvastatin showed higher rates of trigger finger, elbow tendinopathies, and shoulder tendinopathies, but it was not associated with significantly higher rates of De Quervain's tenosynovitis or Achilles tendinopathy.
All remaining statins were grouped into a single “other statins” category and were also found to have significantly higher rates of tendinopathy across all types. The takeaway is that the tendinopathy risk appears to be a class-wide effect — no single statin is entirely free of this association. However, the differences between specific statins and specific tendon types suggest that the mechanism may vary depending on the drug’s molecular properties and how it interacts with different tendon tissues.
Does the Risk Increase the Longer You Take Statins?
One of the most interesting findings from this study relates to how tendinopathy risk changes over time. The researchers measured cumulative defined daily dose (the total amount of medication consumed over time) and found a pattern that may surprise many patients.
The risk of developing tendinopathy was highest in the first three months after starting a statin, with a 134% increase compared to non-users. Between three and six months, the risk remained elevated at 121% higher. However, after six months of continuous use, the risk dropped substantially to only 12% higher than non-users.
Even more notable, when the data was broken down by tendinopathy type, the rates of De Quervain’s tenosynovitis, tennis and golfer’s elbow, and Achilles tendinopathy were no longer significantly different from non-statin users after six months. This suggests that the initial period of statin use represents the highest-risk window, and that individuals who tolerate a statin for six months without developing tendon issues are unlikely to face substantially elevated risk going forward.
One hypothesis for why statins affect tendons involves the induction of matrix metalloproteinases (MMPs), enzymes that can weaken the tendon matrix. Over time, the body may adapt to the medication, reducing this initial vulnerability.
Why Does Metabolic Health Matter for Your Tendons?
It is important to recognize that tendinopathy risk is not solely driven by statin use. Poor metabolic health itself is a powerful and independent risk factor for tendon injury. A prospective cohort study from the Copenhagen City Heart Study by Skovgaard et al. examined the relationship between metabolic markers and tendon injury risk in over 5,800 individuals.
The findings were striking. Individuals with metabolic syndrome — defined as having three or more of the following: excessive abdominal fat, insulin resistance, high blood pressure, abnormal lipid levels, and elevated fasting blood sugar — had approximately 2.5 times higher risk of tendon injury. Those with elevated hemoglobin A1c (a marker for prediabetes and diabetes) had a 3 times higher risk, and those with high cholesterol had a 1.5 times higher risk.
In my practice, I increasingly view tendinopathies as a condition with a significant metabolic component — not purely an overuse or wear-and-tear problem. Many patients who present with recurrent or chronic tendon issues also have underlying metabolic dysfunction. Addressing these metabolic factors is essential for comprehensive treatment and prevention.
How to Improve Your Metabolic Health Without Medication
Regardless of whether you take a statin, improving your metabolic health can reduce your risk of tendon problems and support overall wellness. Here are the evidence-based strategies I recommend to my patients.
Prioritize an Anti-Inflammatory Diet
Minimize your consumption of processed and fried foods, refined carbohydrates, and sugary beverages. These foods have been associated with increased systemic inflammation, insulin resistance, and elevated cardiovascular risk. Instead, focus on foods that actively reduce inflammation and support metabolic function: fruits and vegetables rich in antioxidants, lean proteins such as chicken and fish, plant-based protein sources including nuts, seeds, legumes, and soy, and healthy fats from avocados, olive oil, and fatty fish. The omega-3 fatty acids found in fatty fish are particularly beneficial for their anti-inflammatory properties.
Incorporate Aerobic Exercise Daily
Daily aerobic exercise such as walking, cycling, swimming, elliptical training, or rowing has far-reaching benefits for cardiovascular health, metabolic function, cognitive function, immune health, and weight management. Aim for at least 30 minutes of moderate-intensity aerobic exercise every day.
Add Strength Training to Your Routine
Strength training helps increase muscle mass, improve insulin sensitivity, enhance resting energy expenditure, promote fat loss, and drive positive metabolic adaptations. Aim to perform resistance training at least three times per week, incorporating both upper-body and lower-body exercises. If you are new to strength training or have existing joint concerns, I encourage you to schedule a consultation to develop a safe and effective program.
Should You Stop Taking Your Statin?
This is an important question that requires a nuanced, individualized answer. Every medical decision involves a risk-benefit analysis. Statins have been shown to save lives in patients with established cardiovascular disease or significant risk factors such as diabetes, prior heart attack, or prior stroke. For these high-risk patients, the cardiovascular benefits of statin therapy almost certainly outweigh the modestly increased risk of tendinopathy.
The decision becomes more complex for individuals without established cardiovascular disease or major risk factors. For many of these patients, lifestyle modifications — including dietary changes and regular exercise — may offer a viable alternative or complement to statin therapy. The key is to have an informed discussion with your healthcare provider about your individual risk profile, family history, and treatment goals.
If you are currently taking a statin and experiencing tendon pain, do not stop the medication on your own. Talk to your doctor about your symptoms so that together you can weigh the risks and benefits and explore alternative approaches if appropriate. You can learn more about how I evaluate and treat tendon conditions on my blog or book a visit to discuss your specific situation.
References
1. Kwak D, Moon SJ, Park JW, Lee DH, Lee JI. Effects of Statin Treatment on the Development of Tendinopathy: A Nationwide Population-Based Cohort Study. Orthop J Sports Med. 2023;11(7):23259671231167851. doi:10.1177/23259671231167851
2. Skovgaard D, Siersma VD, Klausen SB, et al. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury. Scand J Med Sci Sports. 2021;31(9):1822-1831. doi:10.1111/sms.13984
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments